Financial Assistance
Newsletter Sign-up
Need Appointment
Contact Us
About Us

Rush University
For Physicians
For Rush Employees
For Students
Bill Payment Center
Rotate
<< Previous | New Search | Return to Search Results | Next >>

William T. Leslie, MD

William T. Leslie, MD
Appointment Request

Or call
(888) 352-RUSH for help arranging an appointment.
Specialty:
  • Oncology, Medical
  • Hematology
  • Internal Medicine
Board Certification:
  • Medical Oncology
  • Hematology
  • Internal Medicine
Faculty Rank: Assistant Professor
Medical or Graduate Education: Oregon Health & Science University School of Medicine
Residency: University of Illinois Medical Center - Internal Medicine
Fellowship: Rush University Medical Center - Hematology/Oncology
Clinical Expertise:
  • Bile duct cancer
  • Colorectal cancer
  • Gallbladder cancer
  • Gastrointestinal cancers
  • Kaposi's sarcoma
  • Liver cancer
  • Pancreatic cancer
  • Squamous cell carcinoma
  • Stomach cancer
Research Interests:
  • Gastrointestinal cancer
Google Map
Google Map
Google Map
Google Map

Below is a list of scientific publications for which this practitioner was either the primary author or a contributor. Citations come from PubMed, a database of biomedical literature, life science journals and online books. PubMed is a service of the US Library of Medicine at the National Institutes of Health. Click on the title of the cited work for more information (this will take you directly to PubMed.gov). Listings go back five years.

  1. Effect of pemetrexed on innate immune killer cells and adaptive immune T cells in subjects with adenocarcinoma of the pancreas.
    Davis M, Conlon K, Bohac GC, Barcenas J, Leslie W, Watkins L, Lamzabi I, Deng Y, Li Y, Plate JM.
    J Immunother. 2012
    2012 Oct
    35(8):629-40.
  2. A Patient With Metastatic Adenocarcinoma of the Jejunum Who Had a Prolonged Complete Response to FOLFOX.
    Lai S, Leslie W.
    Gastrointest Cancer Res. 2012
    2012 Mar
    5(2):71-2. No abstract available.
  3. Successful treatment of anal carcinoma with Paclitaxel, Cisplatin, and radiotherapy in a patient who developed a coronary syndrome from 5-fu.
    Garg S, Abrams RA, Leslie WT.
    Gastrointest Cancer Res. 2012
    2012 Jul
    5(4):135-6. No abstract available.
  4. Treatment of recurrent pediatric gastrointestinal stromal tumors.
    Dave M, Jimenez A, Evans K, Leslie W.
    Gastrointest Cancer Res. 2012
    2012 Jul
    5(4):139-40. No abstract available.
  5. Long-term remission of paroxysmal nocturnal hemoglobinuria following chemoimmunotherapy for non-Hodgkin lymphoma.
    Lai S, Venugopal P, Leslie W.
    Clin Adv Hematol Oncol. 2012
    2012 Feb
    10(2):134-6. No abstract available.
  6. Prognostic Significance of Carbohydrate Antigen 19-9 in Unresectable Locally Advanced Pancreatic Cancer Treated With Dose-Escalated Intensity Modulated Radiation Therapy and Concurrent Full-Dose Gemcitabine: Analysis of a Prospective Phase 1/2 Dose Escalation Study.
    Vainshtein JM, Schipper M, Zalupski MM, Lawrence TS, Abrams R, Francis IR, Khan G, Leslie W, Ben-Josef E.
    Int J Radiat Oncol Biol Phys. 2012
    2012 Dec 19. doi:pii: S0360-3016(12)03817-5. 10.1016/j.ijrobp.2012.11.020. [Epub ahead of print]
  7. A phase I/II trial of intensity modulated radiation (IMRT) dose escalation with concurrent fixed-dose rate gemcitabine (FDR-G) in patients with unresectable pancreatic cancer.
    Ben-Josef E, Schipper M, Francis IR, Hadley S, Ten-Haken R, Lawrence T, Normolle D, Simeone DM, Sonnenday C, Abrams R, Leslie W, Khan G, Zalupski MM.
    Int J Radiat Oncol Biol Phys. 2012
    2012 Dec 1
    84(5):1166-71. doi: 10.1016/j.ijrobp.2012.02.051. Epub 2012 Apr 27.
  8. A patient with necrobiotic xanthogranuloma presenting with an anterior mediastinal mass, plasma cell dyscrasia, and a lymphoproliferative disorder.
    Chen KY, Leslie W, Mahon B, Venugopal P.
    Clin Adv Hematol Oncol. 2011
    2011 Sep
    9(9):696-700. No abstract available.
  9. Prolonged neutropenia after neoadjuvant radiation therapy and chemotherapy using oxaliplatin and capecitabine for rectal cancer.
    McFarland DC, Leslie WT.
    Gastrointest Cancer Res.
    2011 Jan
    4(1):33-5
  10. An Epstein-Barr virus-associated smooth muscle tumor successfully treated with surgical resection: a case report and literature review
    Cela I, Shah NB, Bradly D, Loew J, Leslie W
    Clin Adv Hematol Oncol
    2010 Jun
    8(6):423-6
  11. Neoadjuvant treatment of rectal gastrointestinal stromal tumors with imatinib.
    Turner J, Batus M, Leslie W, Coogan C, Saclarides TJ.
    Am Surg.
    2010 Aug
    76(8):E110-2
  12. Management of a patient with borderline resectable pancreatic cancer. Case report and review
    Shah AP, Strauss JB, Leslie WT, Shah A, Mahon B, Abrams RA
    Oncology (Williston Park)
    2008 Nov 30
    22(13):1524-9
  13. Localized bone disease as a presentation of hairy cell leukemia
    Karmali R, Farhat M, Leslie W, McIntire MG, Gregory S
    Clin Adv Hematol Oncol
    2008 Apr
    6(4):290-4
  • (If you cannot play the video, you may need to update to the latest version of Adobe Flash Player.)
  • View Transcript

Find a Doctor | Patient & Visitor Services | Health Information | Clinical Services | Events & Classes | News Room | Clinical Trials | Research at Rush
Nursing at Rush | Work at Rush | Giving to Rush | Directions to Rush | Disclaimer | Privacy Statement
For Physicians | For Rush Employees | For Students | Bill Payment Center | Site Map
© Rush University Medical Center
1653 W. Congress Parkway, Chicago, Illinois 60612